MICROSUL Drug Patent Profile
✉ Email this page to a colleague
When do Microsul patents expire, and when can generic versions of Microsul launch?
Microsul is a drug marketed by Forest Pharms and is included in one NDA.
The generic ingredient in MICROSUL is sulfamethizole. There are four drug master file entries for this compound. Additional details are available on the sulfamethizole profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MICROSUL?
- What are the global sales for MICROSUL?
- What is Average Wholesale Price for MICROSUL?
Summary for MICROSUL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 94 |
| Patent Applications: | 4,095 |
| DailyMed Link: | MICROSUL at DailyMed |
US Patents and Regulatory Information for MICROSUL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Forest Pharms | MICROSUL | sulfamethizole | TABLET;ORAL | 086012-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
